In a report released today, Joanne Wuensch from Citi maintained a Hold rating on Haemonetics (HAE – Research Report). The company’s shares closed yesterday at $75.05. Discover outperforming ...
(RTTNews) - Haemonetics Corporation (HAE), a provider in medical technology focused on advancing patient outcomes, Tuesday announced that it has finalized the sale of its whole blood assets to GVS ...
BOSTON, Jan. 14, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback